Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 3.82%1.29B | -2.75%1.28B | -21.04%1.2B | -20.98%1.27B | -8.64%1.25B | 2.33%1.32B | 27.97%1.51B | 56.83%1.61B | 33.22%1.36B | -3.33%1.29B |
| Transactional financial assets | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes receivable and accounts receivable | -25.59%787.69M | -13.57%701.47M | -17.14%600.08M | -10.85%849.85M | -12.77%1.06B | -25.12%811.59M | -11.23%724.25M | 12.14%953.3M | 144.26%1.21B | 200.34%1.08B |
| -Notes receivable | -37.25%375.3M | -37.26%250.4M | -36.07%273.32M | -19.54%521.96M | -13.80%598.11M | -31.43%399.08M | -23.44%427.56M | 3.84%648.76M | 1,949.30%693.88M | 1,519.62%582M |
| -Accounts receivable | -10.45%412.39M | 9.35%451.07M | 10.13%326.76M | 7.67%327.89M | -11.40%460.53M | -17.80%412.51M | 15.27%296.69M | 35.15%304.54M | 12.26%519.77M | 54.44%501.86M |
| Other receivables (including interest and dividends) | -73.58%64.04M | -64.94%98.01M | -79.60%43.3M | -79.12%43.36M | 30.89%242.42M | 41.85%279.56M | 1,312.57%212.31M | 532.80%207.63M | 180.51%185.21M | 197.92%197.07M |
| -Dividend receivable | 311.13%32.01M | 688.25%61.38M | -57.11%4.1M | -57.11%4.1M | 254.38%7.79M | 191.95%7.79M | 258.30%9.56M | 258.30%9.56M | -52.15%2.2M | -41.92%2.67M |
| -Accrued interest receivable | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other receivable | ---- | -86.52%36.63M | ---- | ---- | ---- | 39.80%271.77M | ---- | 557.09%198.07M | ---- | 215.82%194.41M |
| Contractual assets | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Advance payment | -31.70%112.37M | -31.74%112.98M | -38.70%103.57M | 52.33%60.95M | 12.25%164.54M | 23.58%165.51M | 22.46%168.97M | -6.52%40.01M | -36.17%146.58M | -12.66%133.93M |
| Inventories | 12.01%712.93M | 0.21%716.85M | -9.53%854.06M | -11.05%642.55M | -5.06%636.47M | 28.69%715.35M | 11.01%943.98M | -17.06%722.38M | 33.75%670.41M | -1.05%555.88M |
| Receivable financing | -3.54%254.12M | 1.13%162.38M | 50.74%128.68M | 49.77%194.52M | 46.31%263.45M | 5.36%160.55M | 22.84%85.37M | 81.46%129.88M | -52.98%180.07M | -69.13%152.39M |
| Assets held for sale | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-current assets due within one year | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 16.18%78.27M | 17.62%80.99M | 3.78%107.32M | 23.89%107.49M | 18.81%67.37M | 37.32%68.86M | 74.87%103.41M | 10.39%86.77M | 169.46%56.7M | -55.47%50.15M |
| Total current assets | -10.22%3.3B | -10.37%3.15B | -19.18%3.03B | -15.44%3.17B | -3.60%3.68B | 1.68%3.52B | 19.84%3.75B | 26.13%3.75B | 40.23%3.82B | 12.35%3.46B |
| Non Current assets | ||||||||||
| Other equity investment | 0.00%30.09M | 0.00%30.09M | 0.00%30.09M | 0.00%30.09M | 0.00%30.09M | 0.00%30.09M | 91.79%30.09M | 91.79%30.09M | 132.55%30.09M | 132.55%30.09M |
| Other non-current financial assets | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment real estate | -7.93%15.16M | -7.62%15.51M | -7.63%15.81M | -7.49%16.14M | -7.35%16.46M | -7.22%16.79M | -7.09%17.12M | -6.96%17.44M | -6.84%17.77M | -6.73%18.1M |
| Long-term equity investment | -12.44%472.4M | -11.86%453.1M | 0.08%517.11M | 1.04%522.1M | 6.51%539.52M | 2.53%514.08M | 3.12%516.71M | 0.59%516.71M | 3.51%506.53M | 4.12%501.4M |
| Fixed assets | ---- | 5.56%4.52B | ---- | ---- | ---- | -3.02%4.28B | ---- | 3.50%4.42B | ---- | 2.05%4.42B |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | --9.76M | ---- | ---- | ---- | ---- |
| Constru in process | ---- | -15.85%411.96M | ---- | ---- | ---- | 101.30%489.56M | ---- | -18.71%290.05M | ---- | 23.69%243.2M |
| Productive biological assets | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Oil and gas assets | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Intangible assets | 13.71%460.55M | 13.56%445.37M | 16.79%452.4M | 9.91%431.38M | 10.59%405.01M | 6.64%392.19M | 4.10%387.38M | 4.58%392.48M | -32.16%366.21M | -31.59%367.77M |
| Development expenditure | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Goodwill | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Long deferred expense | 101.86%24.13M | 52.40%18.33M | 217.36%19.92M | 233.72%21.51M | 212.67%11.96M | 191.56%12.03M | 49.64%6.28M | 200.61%6.44M | 231.71%3.82M | 237.57%4.12M |
| Deferred tax assets | -25.69%14.6M | -26.29%15.83M | -27.05%15.66M | -26.20%16.22M | 15.38%19.65M | 28.18%21.48M | 9.00%21.46M | 2.32%21.98M | -32.60%17.03M | -33.19%16.76M |
| Usufruct assets | --1.34M | --1.36M | ---- | ---- | ---- | ---- | -92.31%14.57K | -99.92%58.28K | -99.87%102K | -99.82%145.71K |
| Other non current assets | 96.78%407.84M | 90.19%406.51M | 87.95%410.23M | 71.22%420.18M | -9.30%207.25M | -9.98%213.74M | -8.88%218.26M | -1.81%245.4M | -17.71%228.51M | -18.67%237.43M |
| Total non current assets | 5.39%6.36B | 5.62%6.32B | 7.43%6.34B | 7.11%6.37B | 3.51%6.03B | 2.52%5.98B | 1.31%5.91B | 0.69%5.94B | -2.50%5.83B | -2.32%5.84B |
| Total assets | -0.52%9.66B | -0.30%9.47B | -2.91%9.38B | -1.62%9.54B | 0.70%9.71B | 2.21%9.5B | 7.79%9.66B | 9.21%9.69B | 10.87%9.64B | 2.67%9.3B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -42.15%373.5M | -47.44%443.48M | -59.98%493.02M | -57.73%495.15M | -27.83%645.6M | -16.52%843.8M | 38.45%1.23B | 2.64%1.17B | -22.21%894.55M | -27.29%1.01B |
| Transactional financial liabilities | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | 13.66%563.82M | -3.29%467.62M | 10.66%479.51M | 0.48%517.32M | -14.16%496.05M | -1.08%483.51M | 30.15%433.33M | 12.03%514.83M | 3.66%577.9M | -26.15%488.77M |
| -Notes payable | --97.91M | 860.18%6.88M | -85.64%6.88M | -85.67%6.88M | ---- | -98.94%716.74K | 350.52%47.93M | -17.70%48.04M | -63.13%57.92M | -67.35%67.73M |
| -Accounts payable | -6.08%465.91M | -4.57%460.74M | 22.63%472.63M | 9.35%510.43M | -4.60%496.05M | 14.67%482.79M | 19.58%385.4M | 16.35%466.79M | 29.86%519.99M | -7.33%421.04M |
| Contract liabilities | -31.02%87.85M | -29.41%70.28M | -36.07%98.89M | -39.49%59.3M | 27.94%127.36M | 7.34%99.56M | 34.23%154.7M | -9.00%97.99M | -29.34%99.55M | -23.15%92.75M |
| Advance receipts | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Salaries payable | 134.06%52.63M | -24.36%23.78M | -28.98%23.36M | -33.81%49.21M | -62.29%22.48M | -28.10%31.44M | -36.20%32.89M | -18.95%74.36M | 13.34%59.63M | -19.62%43.73M |
| Taxs payable | -10.26%65.78M | -33.43%40.79M | 2.33%21.79M | -27.25%20.88M | -19.08%73.3M | -18.72%61.28M | -68.78%21.3M | -63.64%28.7M | -41.46%90.58M | -41.48%75.39M |
| Other payable (including interest and dividends) | -16.22%127.67M | -21.33%139.16M | -13.51%145.26M | 8.21%151.09M | 3.45%152.39M | -2.63%176.89M | -7.00%167.95M | -21.53%139.62M | -27.27%147.31M | -17.46%181.67M |
| -Interest payable | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Dividend payable | -31.03%9.87M | 0.00%14.32M | 0.00%14.32M | 41.56%20.27M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M |
| -Other payable | ---- | -23.21%124.85M | ---- | ---- | ---- | -2.86%162.57M | ---- | -23.41%125.31M | ---- | -18.68%167.35M |
| Hold and for sell liabilities | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Non current liabilities due within one year | 5,256.39%212.17M | 3,882.70%229.45M | 2,047.42%256.11M | 397.67%261.24M | -98.75%3.96M | -98.41%5.76M | -96.87%11.93M | -90.87%52.49M | 1,240.08%316.57M | 98.75%361.57M |
| Other current liabilities | -35.40%198.18M | 20.75%241.46M | -43.37%179.95M | -24.20%281.87M | -24.69%306.78M | -46.14%199.97M | -18.45%317.75M | 3.96%371.87M | 1,191.74%407.35M | 1,099.45%371.28M |
| Total current liabilities | -8.01%1.68B | -12.94%1.66B | -28.41%1.7B | -25.10%1.84B | -29.52%1.83B | -27.56%1.9B | -1.53%2.37B | -18.02%2.45B | 12.10%2.59B | -5.84%2.63B |
| Current liabilities | ||||||||||
| Long term loan | -10.81%897.01M | 1.91%947.51M | 19.49%848.92M | 23.36%811.75M | 149.74%1.01B | 235.62%929.77M | 158.00%710.44M | 139.12%658.03M | -46.57%402.72M | -66.37%277.03M |
| Bonds payable | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Preferred stock | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Perpetual Debt | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Long term account payable | ---- | 28,394.07%59.31M | ---- | ---- | ---- | -31.60%208.16K | ---- | -48.03%208.16K | ---- | -24.02%304.34K |
| Long term salaries pay | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Estimate liabilities | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Long term deferred income | 34.90%171.29M | 35.92%170.89M | 16.93%148.48M | 21.70%144.27M | 7.72%126.98M | 4.52%125.73M | 4.04%126.98M | -4.94%118.54M | -6.11%117.88M | -0.45%120.29M |
| Lease liabilities | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non current liabilities | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | -0.48%1.13B | 11.56%1.18B | 26.16%1.06B | 30.71%1.02B | 117.50%1.13B | 165.50%1.06B | 110.61%837.63M | 94.05%776.78M | -41.68%520.91M | -58.52%397.62M |
| Total liabilities | -5.13%2.81B | -4.20%2.83B | -14.17%2.75B | -11.67%2.85B | -4.93%2.96B | -2.17%2.96B | 14.36%3.21B | -4.78%3.23B | -2.88%3.11B | -19.32%3.02B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.6B | 0.00%1.6B | 0.00%1.6B | 0.00%1.6B | 0.00%1.6B | 0.00%1.6B | 0.00%1.6B | 16.38%1.6B | 16.38%1.6B | 16.38%1.6B |
| Other equity instruments | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Equity of prefer stock | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Equity of Perpetual debt | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Capital reserve funds | 0.00%3.4B | -1.22%3.4B | -1.20%3.4B | -1.20%3.4B | -1.20%3.4B | 0.02%3.45B | 0.00%3.44B | 14.65%3.44B | 14.65%3.44B | 14.65%3.44B |
| Surplus reserve funds | 14.87%238.89M | 14.87%238.89M | 14.87%238.89M | 14.87%238.89M | 9.34%207.97M | 9.34%207.97M | 9.34%207.97M | 9.34%207.97M | 5.78%190.21M | 5.78%190.21M |
| Retained profit | 6.05%1.22B | 5.90%1.02B | 13.49%1.02B | 17.85%1.07B | 18.77%1.15B | 31.67%963.67M | 41.86%894.91M | 45.71%908.93M | 57.41%971.67M | 55.92%731.89M |
| Less:Treasury stock | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other composite income | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Specific reserves | -10.46%65.42M | -4.69%63.44M | -3.73%61.74M | 16.14%72.24M | -3.34%73.05M | -9.17%66.56M | -7.13%64.13M | -4.30%62.2M | 9.47%75.58M | 48.45%73.28M |
| Shareholders equity without minority interests | 1.44%6.54B | 0.68%6.33B | 1.74%6.32B | 2.60%6.39B | 2.49%6.44B | 4.03%6.29B | 4.66%6.22B | 18.36%6.23B | 19.76%6.29B | 18.95%6.04B |
| Minority interests | 2.58%315.71M | 20.73%307.55M | 28.30%297.26M | 24.46%295.59M | 26.35%307.76M | 12.09%254.75M | 8.30%231.69M | 6.00%237.49M | 0.17%243.57M | 1.24%227.27M |
| Total shareholder equity | 1.50%6.85B | 1.46%6.64B | 2.69%6.62B | 3.40%6.69B | 3.38%6.75B | 4.32%6.54B | 4.79%6.45B | 17.86%6.47B | 18.90%6.53B | 18.20%6.27B |
| Total liabilityies and equity | -0.52%9.66B | -0.30%9.47B | -2.91%9.38B | -1.62%9.54B | 0.70%9.71B | 2.21%9.5B | 7.79%9.66B | 9.21%9.69B | 10.87%9.64B | 2.67%9.3B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.